期刊文献+

超声联合肿瘤标志物预测附件包块良恶性质的临床价值 被引量:4

The clinical value of ultrasound combined with tumor markers in predicting adnexal masses
原文传递
导出
摘要 目的研究术前超声联合肿瘤标志物预测附件包块良恶性质的临床价值。方法回顾性分析2009年1月至2010年10月间,于同济大学附属第一妇婴保健院收治的475例附件包块患者,术前超声评估附件包块性质(包括肿块大小,回声性质和血流信号)和肿瘤标志物(CA125、CA199、AFP、CEA和CA153)检查,与最终手术病理结果比较。结果手术石蜡病理提示卵巢恶性肿瘤100例,交界性肿瘤50例,良性肿瘤325例。术前超声提示囊性肿块183例,其中良性144例(78.7%)、恶性19例(10.4%);超声提示混合性肿块247例,其中良性160例(64.8%)、恶性58例(23.5%);超声提示实性肿块45例,其中良性21例(46.7%)、恶性23例(51.1%)。超声提示混合性或实性肿块与囊性肿块相比,卵巢恶性肿瘤病率显著增加(27.7%vs.10.4%)(P<0.001)。提出卵巢肿瘤预测模型1、2、3,模型1:CA125≥35kU/L+超声混合或实性;模型2:CA125≥100kU/L+超声混合或实性;模型3:CA125≥35kU/L+CA199≥37kU/L+超声混合或实性。结论超声提示附件混合性或实性包块同时合并CA125升高者,卵巢恶性肿瘤发生率显著增高。 Objective To assess the value of preoperative uhrasonography combined with tumor markers in predicting benign or malignant adnexal mass. Methods Between Jan. 2009 and Oct. 2010, 475 patients with adnexal mass underwent surgery in Shanghai First Maternal and Infant Hospital. Tumor morphology derived from ultrasonographic images, tumor size, tumor bilaterality, tumor markers, and patient demographics were evaluated preoperatively find compared with paraf- fin pathologic diagnosis. Muhivariable classification and regression tree analysis were used to predict benign or malignant adnexal mass. Result Among 475 patients in this study, 100 patients with ovarian cancer, 50 with borderline ovarian tumors and 325 with benign ovarian tumors were certified by final paraffin diagnosis. Tumor morphology was classified in- to cystic, solid or complex by ultrasonography. 144 (78.7%) of 183 cystic adnexal masses were benign, 19 ( 10. 4% ) were malignant. 160 ( 64. 8% ) of 247 complex adnexal masses were benign, 58 ( 23.5% ) were malignant. 21 (46. 7% ) of 45 solid adnexal masses were benign, 23 (51.1%) were malignant. Risk of malignancy in a complex or solid adnexal mass was significantly higher than that in cystic mass (P 〈 0. 001 ). Ovarian Cancer Predicting Model 1,2, 3 were designed. Model 1 : CA125 ≥35kU/L combined with solid or complex mass in tumor morphology. Model 2 : CA125 ≥ 100kU/L combined with solid or complex mass. Model 3:CA125 ≥35kU/L and CA199 ≥37kU/L combined with solid or complex mass. Conclusion The complex and solid echo of ultrasonographic images combined with CA125 (35kU/L could predict malignancy disease of ovary efficiently.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2012年第2期127-130,共4页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 附件包块 彩色多普勒超声 CA125 预测 adnexal mass Doppler ultrasonography CA125 prediction
  • 相关文献

参考文献13

  • 1Young R, Walton L, Ellenberg S, et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer, result of two pro- spective randomized trial[ J ]. N Engl J Med, 1990, 322: 1021- 1024.
  • 2Jacobs I, Oram I), Fairbanks J, et al. A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer [ J ]. Br J Ob- stet Gynaecol, 1990,97 (10) :922-929.
  • 3Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses [ J ]. Br J Obstet Gynaecol, 1996,103 ( 8 ) :826-831.
  • 4Roman LD. Small cystic pelvic masses in older women: is surgi- cal removal necessary? [ J]. Gynecol Oncol, 1998,69 : 1-2.
  • 5ModesittSC, Pavlik EJ, Ueland FR, et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 cm in diameter: a long-term follow-up study[J]. Obstet Gynecol,2003,102:594- 599.
  • 6McDonald JM, Doran S, DeSimone CP, et al. Predicting risk of malignancy in adnexal masses [ J ]. Obstet Gynecol, 2010,115 : 687-694.
  • 7Karam AK,Karlan BY. Ovarian cancer: the duplicity of CA125 measurement [ J ]. Nat Rev Clin Oneol, 2010,7 (6) :335-339.
  • 8Han L Y,Karavasilis V, Hagen T, et al. Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy [ J ]. Eur J Cancer,2010,46 ( 8 ) : 1359-1364.
  • 9Kang WD,Choi HS, Kim SM. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer [ J]. Gynecol Oncol, 2010,116 ( 1 ) :57-60.
  • 10Jacobs I, DaviesA, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA125 measurement and uhrasonography [ J ]. BMJ, 1993, 306 : 1030-1035.

同被引文献31

  • 1魏奇龙,吴敏,林健谊.多普勒超声与MRI在诊断女性盆腔囊性肿块中的应用比较[J].中国CT和MRI杂志,2020,18(1):140-142. 被引量:19
  • 2崔美兰,王庆一,赵春平,杨文娟.HE4、CA125和CA72-4联合检测对卵巢恶性肿瘤的诊断价值[J].中国老年学杂志,2014,34(3):614-615. 被引量:7
  • 3Kurman R J, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory [ J ]. Am J Surg Pathol, 2010,34 (3) :433-443.
  • 4Kurman R J, Shih IeM. PCOS, Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm [ J ]. Hum Pathol,2011,42(7) :918-931.
  • 5Kaijser J, Bourne T, Valentin L, et al. Improving strategies for diagno- sing ovarian cancer:a summary of the International Ovarian Tumor A- nalysis (IOTA) studies [ J ]. Ultrasound Obstet Gynecol, 2013,41 ( 1 ) : 9-20.
  • 6Moss EL, Moran A, Reynolds TM, et al. Views of general practitioners on the role of CA125 in primary care to diagnose ovarian cancer[ J]. BMC Womens Health,2013,13( 1 ) :8.
  • 7Greenlee RT, Kessel B, Williams CR, et al. Prevalence, incidence, and natural history of simple ovarian cysts among women > 55 years old in a large cancer screening trial [ J]. Am J Obstet Gynecol, 2010,202 (4) :1-9.
  • 8Gulee UK, Paydas S, Guzel AB, et al. The relationship between ovarian volume and serum CA-125 levels [ J 1. Eur J Gynaecol Oncol,2014,35 (3) :280-283.
  • 9Levy T, Weiser R, Boaz M, et al. The significance of the pattern of se- rum CA125 level ascent to above the normal range in epithelial ovari- an, primary peritoneal and tubal carcinoma patients [ J ]. Gynecol On- col ,2013,129 ( 1 ) :165-168.
  • 10Karlan BY,Thorpe J,Watabayashi K,et al. Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women[ J]. Cancer Epidemiol Biomarkers Prey,2014,23 (7) : 1383-1393.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部